Found 1 articles for: "Dermal Safety"

Dermal Safety of Tapinarof Cream 1%: Results From 4 Phase 1 Trials

October 2022 | Volume 21 | Issue 10 | Original Article | 1084 | Copyright © October 2022

Background: Tapinarof (VTAMA^®; Dermavant Sciences, Inc.) is a novel, non-steroidal, topical, aryl hydrocarbon receptor agonist, FDA approved for psoriasis treatment and...
Read More